134 related articles for article (PubMed ID: 24906399)
1. Response.
Glezerman IG; Hu MI; Jain RK
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906399
[No Abstract] [Full Text] [Related]
2. RE: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Adhikaree J; Newby Y; Sundar S
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663690
[No Abstract] [Full Text] [Related]
3. Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Tsuda M; Ishiguro H; Yano I; Toi M
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906398
[No Abstract] [Full Text] [Related]
4. Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Hu MI; Glezerman I; Leboulleux S; Insogna K; Gucalp R; Misiorowski W; Yu B; Ying W; Jain RK
J Natl Cancer Inst; 2013 Sep; 105(18):1417-20. PubMed ID: 23990665
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.
Lin PH; Chiu CF; Lu YS
Ann Oncol; 2011 May; 22(5):1244-1246. PubMed ID: 21460375
[No Abstract] [Full Text] [Related]
6. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis].
Abe M
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):675-80. PubMed ID: 17506303
[No Abstract] [Full Text] [Related]
7. The pharmacological management of skeletal-related events from metastatic tumors.
Hitron A; Adams V
Orthopedics; 2009 Mar; 32(3):188. PubMed ID: 19309055
[TBL] [Abstract][Full Text] [Related]
8. [Management of bone metastases].
Nagykálnai T; Landherr L
Orv Hetil; 2014 Feb; 155(6):217-25. PubMed ID: 24486845
[TBL] [Abstract][Full Text] [Related]
9. Reply to Araki et al.
Lipton A; Fizazi K; Stopeck AT; Henry DH; Braun AH
Eur J Cancer; 2013 Jun; 49(9):2266-8. PubMed ID: 23578571
[No Abstract] [Full Text] [Related]
10. [Integrated analysis of three pivotal trials].
Kurth A
Orthopade; 2014 Feb; 43(2):182. PubMed ID: 24693556
[No Abstract] [Full Text] [Related]
11. Treatment of bisphosphonate-resistant hypercalcemia of malignancy with calcitonin.
Dawson C; Todd AM; Walton A
J Palliat Med; 2014 Oct; 17(10):1084. PubMed ID: 25265187
[No Abstract] [Full Text] [Related]
12. Cancer induced bone pain.
Kane CM; Hoskin P; Bennett MI
BMJ; 2015 Jan; 350():h315. PubMed ID: 25633978
[No Abstract] [Full Text] [Related]
13. Bisphosphonates--role in cancer therapies.
Mehrotra B
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
[No Abstract] [Full Text] [Related]
14. Why denosumab obtains a survival benefit over zoledronic acid in bone metastatic lung cancer patients?
Deiana L; Claps M; Berruti A
J Thorac Oncol; 2013 Aug; 8(8):e79. PubMed ID: 23857407
[No Abstract] [Full Text] [Related]
15. Re: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of three pivotal, randomised, phase 3 trials.
Araki K; Ito Y; Takahashi S
Eur J Cancer; 2013 Jun; 49(9):2264-5. PubMed ID: 23541567
[No Abstract] [Full Text] [Related]
16. Hypercalcemia and gallium nitrate.
Gucalp R
J Support Oncol; 2004; 2(6):518-20. PubMed ID: 16329218
[No Abstract] [Full Text] [Related]
17. [Bone targeting agents: bisphosphonates].
Debiais F
Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate or RANK-L inhibitor for tumour-induced hypercalcaemia?
Bech A; Essink G; de Boer H
Neth J Med; 2012 Jun; 70(5):250-1. PubMed ID: 22744931
[No Abstract] [Full Text] [Related]
19. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
[No Abstract] [Full Text] [Related]
20. Commentary on 'Pamidronate: treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis' by Alos N. et al., Hormone Research 2006;65:289-294.
Lombet J
Horm Res; 2008; 70(4):254-5; author reply 256. PubMed ID: 18772600
[No Abstract] [Full Text] [Related]
[Next] [New Search]
